Maze Therapeutics (MAZE) Earnings Analysis
Maze Therapeutics (MAZE) next reports earnings on 2026-08-11, consensus EPS -0.76 USD. Last quarter (2026-03-25) it beat with EPS -0.65 USD vs -0.73 USD est (+11%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -10.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MAZE next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.76 USD |
| Revenue estimate | 0.00B |
MAZE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-25 | -0.65 USD | -0.73 USD | +11% | Beat |
| 2025-11-06 | -0.66 USD | -0.74 USD | +10.8% | Beat |
| 2025-03-31 | -18.32 USD | 0.45 USD | -4171.1% | Miss |
| 2024-09-30 | -0.56541 USD | n/a | n/a | n/a |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
MAZE valuation and analyst view
| Trailing P/E | -10.36 |
|---|---|
| Trailing EPS | -2.27362 USD |
| Price / book | 4.49 |
| Dividend yield | 0.00% |
| Market cap | 1.57B |
| Analyst consensus | Buy (6 buy / 0 hold / 0 sell) |
| Avg price target | 54.8 USD |
Related research pages
Frequently asked questions
When is Maze Therapeutics (MAZE)'s next earnings date?
Maze Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.76 USD and revenue estimate of 0.00B.
Did MAZE beat earnings last quarter?
In its 2026-03-25 report, MAZE posted EPS of -0.65 USD versus a -0.73 USD estimate — a beat of 11%.
What is MAZE's earnings track record?
Over the last 3 reported quarters with consensus data, MAZE beat estimates 2 times (67%).
What is MAZE's current P/E ratio and EPS?
MAZE trades at a trailing P/E of -10.36 on trailing EPS of -2.2736239289242697 USD.
What do analysts rate MAZE?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 54.8 USD.